http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030087029-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20030087029-A |
| titleOfInvention | Remedies for retina and choroid diseases containing steroids as the active ingredient |
| abstract | It is an object of the present invention to provide a formulation for treating retinopathy disease, which can be easily administered a therapeutic agent for retinopathy disease and a steroid agent comprising the steroid having an effect superior to that of the prior art.n n n The present invention relates to a therapeutic agent for retinal diseases comprising beta mesazone and hydrocortisone as an active ingredient and a subconjunctival injection using steroid as an active ingredient. |
| priorityDate | 2001-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.